It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Which Low Cost Index Funds For Retirement 2024 helps readers evaluate options based on fees, diversification, and suitability for retirement plans.
26,691 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
As markets wobble in early 2026, investors are increasingly pursuing a hybrid approach that blends bonds and dividend...
U.S. stocks slide as oil prices push above $100 a barrel, triggering a risk-off mood that weighs on the S&P 500 and b...
A mega-cap AI stock has defied the hype by turning into the unexpected bargain of the Magnificent Seven. Learn what t...
A fresh BEA release shows the U.S. consumer draining savings while income grows slowly, signaling trouble ahead for g...
Peloton’s leadership change nudges the stock market today into focus. This article breaks down what Sid Thacker’s CFO...
In 2026, smart borrowers look beyond the big banks to find better loan terms. This guide highlights three markets whe...
Even small investors might overlook the protective and strategic power of an LLC. This guide explains how an LLC can ...
Microsoft’s AI chief predicts broad automation of office work within 18 months, a forecast senior economists say coul...
As markets weigh the politics of a Trump-backed Fed chair, investors need a plan. This opinion piece breaks down pote...
June Signals a Shift: AMC's uptick on strong May attendance is fueling momentum across the market. This piece breaks ...
Aflac has a remarkable 43-year streak of raising its dividend, a hallmark many income investors look for. But that st...